Form 8-K - Current report:
SEC Accession No. 0001213900-24-096981
Filing Date
2024-11-13
Accepted
2024-11-12 18:42:37
Documents
13
Period of Report
2024-11-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea022096701-8k_elevai.htm   iXBRL 8-K 27523
  Complete submission text file 0001213900-24-096981.txt   203590

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE elab-20241107.xsd EX-101.SCH 3021
3 XBRL LABEL FILE elab-20241107_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE elab-20241107_pre.xml EX-101.PRE 22363
15 EXTRACTED XBRL INSTANCE DOCUMENT ea022096701-8k_elevai_htm.xml XML 3797
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 241450515
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)